Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.

Summary

The primary objective of this study was to perform a variety of assays on blood, serum, nasal wash and cell samples obtained from healthy adult subjects for the purposes of developing assays for application in the further investigation of immune responses generated by influenza virus vaccine, trivalent, types A \& B, live, cold-adapted (liquid formulation CAIV-T; Wyeth, Marietta, PA).

Timeline

Start

2001-09

Primary completion

2001-12

Completion

2001-12

Drugs

Indications